0 Bedömningar
ID

44719

Beskrivning

see http://clinicaltrials.gov/ct2/show/record/NCT00617669 Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer

Länk

http://clinicaltrials.gov/ct2/show/record/NCT00617669

Nyckelord

Versioner (6)
  1. 2011-11-15 2011-11-15 -
  2. 2014-03-23 2014-03-23 - Martin Dugas
  3. 2014-08-10 2014-08-10 - Martin Dugas
  4. 2021-04-13 2021-04-13 - Dr. rer. medic Philipp Neuhaus
  5. 2021-09-20 2021-09-20 -
  6. 2021-09-28 2021-09-28 - Sarah Riepenhausen
Rättsinnehavare

AstraZeneca

Uppladdad den

28 september 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Eligibility DRKS00005404 NCT00617669 Prostate Cancer

    Engelsk

    Eligibility NCT00617669

    1 Formulär  
    1. StudyEvent: Eligibility
      1. Eligibility NCT00617669
    Inclusion Criteria
    Beskrivning

    Inclusion Criteria

    Alias
    UMLS CUI-1
    C1512693
    18 Years and older
    Beskrivning

    Age

    Datatyp

    integer

    Måttenheter
    • years
    Alias
    UMLS CUI-1
    C0001779
    years
    male
    Beskrivning

    Gender Male

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0086582
    Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
    Beskrivning

    Prostate Cancer with bone metastasis

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0600139
    UMLS CUI-2
    C0153690
    Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
    Beskrivning

    PSA increase

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0138741
    Currently receiving treatment with surgical or medical castration
    Beskrivning

    Castration

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0007347
    Exclusion Criteria
    Beskrivning

    Exclusion Criteria

    Alias
    UMLS CUI-1
    C0680251
    Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
    Beskrivning

    Previous chemotherapy

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0205156
    UMLS CUI-2
    C0392920
    Suffering from heart failure or had a myocardial infarction within last 6 months
    Beskrivning

    Heart disease

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0018801
    UMLS CUI [1,2]
    C0155626
    A history of epilepsy or seizures
    Beskrivning

    Epilepsy, seizures

    Datatyp

    boolean

    Alias
    UMLS CUI-1
    C0014544
    UMLS CUI-2
    C0036572
    Tillbaka till toppen

    Similar models

    Eligibility NCT00617669

    1 Formulär
    1. StudyEvent: Eligibility
      1. Eligibility NCT00617669
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Inclusion Criteria
    C1512693 (UMLS CUI-1)
    Age
    Item
    18 Years and older
    integer
    C0001779 (UMLS CUI-1)
    Gender Male
    Item
    male
    boolean
    C0086582 (UMLS CUI-1)
    Prostate Cancer with bone metastasis
    Item
    Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
    boolean
    C0600139 (UMLS CUI-1)
    C0153690 (UMLS CUI-2)
    PSA increase
    Item
    Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
    boolean
    C0138741 (UMLS CUI-1)
    Castration
    Item
    Currently receiving treatment with surgical or medical castration
    boolean
    C0007347 (UMLS CUI-1)
    Item Group
    Exclusion Criteria
    C0680251 (UMLS CUI-1)
    Previous chemotherapy
    Item
    Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
    boolean
    C0205156 (UMLS CUI-1)
    C0392920 (UMLS CUI-2)
    Heart disease
    Item
    Suffering from heart failure or had a myocardial infarction within last 6 months
    boolean
    C0018801 (UMLS CUI [1,1])
    C0155626 (UMLS CUI [1,2])
    Epilepsy, seizures
    Item
    A history of epilepsy or seizures
    boolean
    C0014544 (UMLS CUI-1)
    C0036572 (UMLS CUI-2)
    Tillbaka till toppen 

    Kontakt

    Använd detta formulär för feedback, frågor och förslag på förbättringar.

    Fält markerade med * är obligatoriska.

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial